Imminent extinction of brachy(saurus)therapy for the treatment of in-stent restenosis.
Moliterno
David J
DJ
Gill Heart Institute and Division of Cardiovascular Medicine, University of Kentucky, Lexington, Kentucky 40536-0200, USA. moliterno@uky.edu
D019917:Blood Vessel Prosthesis Implantation; D001918:Brachytherapy; D002317:Cardiovascular Agents / Q000627:therapeutic use*; D020099:Coated Materials, Biocompatible / Q000627:therapeutic use*; D017023:Coronary Angiography; D023903:Coronary Restenosis / Q000000981:diagnostic imaging / Q000628:therapy*; D004869:Equipment Safety; D006801:Humans; D017239:Paclitaxel / Q000627:therapeutic use*; D011108:Polymers / Q000627:therapeutic use; D015607:Stents; D020946:Taxus
D002317:Cardiovascular Agents; D020099:Coated Materials, Biocompatible; D011108:Polymers; D017239:Paclitaxel